Safety And Efficacy Study Of Topic Mucopolysaccharide Polysulfate In The Superficial Varicose Veins Treatment

• Status: Withdrawn
• Trial end date: 2015-02-01
• Target enrollment: 0
• Participant gender: All

Summary

Evaluate the safety, tolerability and effectiveness of mucopolysaccharide polysulfate in the treatment of superficial varicose veins

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: EMS

Criteria

Inclusion Criteria:

• Patients must be able to understand the study procedures, agree to participate, and give written consent.

• Patients must be able to follow the study medication regimen.

• Patients with inflammatory process in superficial veins for more than 72 hours.

• Presence of symmetric lesions to compare one side to the other.

Exclusion Criteria:

• Pregnancy or risk of pregnancy.

• Lactation.

• Use of topical or systemic anti-inflammatory, antihistamine or immunosuppressive drugs within the last 48 hours prior to the study

• Any alteration at other deep veins.

• History of atopy or allergic diseases.

• History of allergy to any component of the formulations.

• Other conditions considered by the investigator as reasonable for non-eligibility.